Literature DB >> 29318894

Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.

William S Oetting1, Baolin Wu2, David P Schladt3, Weihua Guan2, Rory P Remmel4, Casey Dorr3,5, Roslyn B Mannon6, Arthur J Matas7, Ajay K Israni3,8,9, Pamala A Jacobson1.   

Abstract

AIM: Multiple genetic variants have been associated with variation in tacrolimus (TAC) trough concentrations. Unfortunately, additional studies do not confirm these associations, leading one to question if a reported association is accurate and reliable. We attempted to validate 44 published variants associated with TAC trough concentrations. MATERIALS &
METHODS: Genotypes of the variants in our cohort of 1923 kidney allograft recipients were associated with TAC trough concentrations.
RESULTS: Only variants in CYP3A4 and CYP3A5 were significantly associated with variation in TAC trough concentrations in our validation.
CONCLUSION: There is no evidence that common variants outside the CYP3A4 and CYP3A5 loci are associated with variation in TAC trough concentrations. In the future rare variants may be important and identified using DNA sequencing.

Entities:  

Keywords:  CYP3A5; GWAS; kidney; tacrolimus; transplantation

Mesh:

Substances:

Year:  2018        PMID: 29318894      PMCID: PMC6021962          DOI: 10.2217/pgs-2017-0187

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  62 in total

1.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

2.  A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform.

Authors:  Y Choi; F Jiang; H An; H J Park; J H Choi; H Lee
Journal:  Pharmacogenomics J       Date:  2016-12-13       Impact factor: 3.550

3.  Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.

Authors:  X-J Shi; F Geng; Z Jiao; X-Y Cui; X-Y Qiu; M-K Zhong
Journal:  J Clin Pharm Ther       Date:  2010-10-05       Impact factor: 2.512

4.  Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients.

Authors:  Diego Alberto C Cusinato; Riccardo Lacchini; Elen A Romao; Miguel Moysés-Neto; Eduardo B Coelho
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

5.  Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients.

Authors:  Jiazhen Xing; Xiaoqing Zhang; Junwei Fan; Bin Shen; Tongyi Men; Jianning Wang
Journal:  Eur J Clin Pharmacol       Date:  2014-12-10       Impact factor: 2.953

6.  Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Samer K Khaled; Joycelynne M Palmer; Josef Herzog; Tracey Stiller; Ni-Chun Tsai; David Senitzer; Xueli Liu; Sandra H Thomas; Sepideh Shayani; Jeffrey Weitzel; Stephen J Forman; Ryotaro Nakamura
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-30       Impact factor: 5.742

7.  Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics.

Authors:  Ajay K Israni; Samy M Riad; Robert Leduc; William S Oetting; Weihua Guan; David Schladt; Arthur J Matas; Pamala A Jacobson
Journal:  Transpl Int       Date:  2013-07-24       Impact factor: 3.782

8.  1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation.

Authors:  Laure Elens; Arnaud Capron; Valérie Van Kerckhove; Jan Lerut; Michel Mourad; Dominique Lison; Pierre Wallemacq; Vincent Haufroid
Journal:  Pharmacogenet Genomics       Date:  2007-10       Impact factor: 2.089

9.  Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients.

Authors:  Al-Motassem Yousef; Hisham Qosa; Nailya Bulatova; Ali Abuhaliema; Hussein Almadhoun; Ghada Khayyat; Muhammad Olemat
Journal:  Iran J Kidney Dis       Date:  2016-05       Impact factor: 0.892

10.  Novel single nucleotide polymorphisms in interleukin 6 affect tacrolimus metabolism in liver transplant patients.

Authors:  Dawei Chen; Junwei Fan; Feng Guo; Shengying Qin; Zhaowen Wang; Zhihai Peng
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

View more
  12 in total

1.  Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.

Authors:  William S Oetting; Baolin Wu; David P Schladt; Weihua Guan; Jessica van Setten; Brendan J Keating; David Iklé; Rory P Remmel; Casey R Dorr; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

2.  Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.

Authors:  William S Oetting; David P Schladt; Casey R Dorr; Baolin Wu; Weihua Guan; Rory P Remmel; David Iklé; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

Review 3.  Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.

Authors:  Camille Tron; Florian Lemaitre; Céline Verstuyft; Antoine Petitcollin; Marie-Clémence Verdier; Eric Bellissant
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

4.  CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients.

Authors:  Janaína B F Everton; Fernando J B Patrício; Manuel S Faria; Teresa C A Ferreira; Elen A Romao; Gyl E B Silva; Marcelo Magalhães
Journal:  Eur J Clin Pharmacol       Date:  2021-01-05       Impact factor: 2.953

5.  Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups.

Authors:  Moataz E Mohamed; David P Schladt; Weihua Guan; Baolin Wu; Jessica van Setten; Brendan J Keating; David Iklé; Rory P Remmel; Casey R Dorr; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; William S Oetting; Pamala A Jacobson
Journal:  Am J Transplant       Date:  2019-05-13       Impact factor: 8.086

6.  The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients.

Authors:  Zhaolin Chen; Xi Cheng; Liwen Zhang; Liqin Tang; Yan Fang; Hongxiao Chen; Lei Zhang; Aizong Shen
Journal:  Pharmacol Rep       Date:  2021-06-05       Impact factor: 3.024

7.  Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients.

Authors:  Dina Chen; Huijie Lu; Weiguo Sui; Liqing Li; Jian Xu; Tengfei Yang; Siyao Yang; Ping Zheng; Yan Chen; Jiejing Chen; Wen Xue; Qingping Li; Que Zheng; Demei Ye; Wolfgang Sadee; Danxin Wang; Wanying Qian; Liusheng Lai; Chuanjiang Li; Liang Li
Journal:  Pharmacogenomics J       Date:  2021-03-01       Impact factor: 3.550

8.  CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients.

Authors:  Paola Krall; Dominique Yañez; Angélica Rojo; Ángela Delucchi; Miguel Córdova; Jorge Morales; Pía Boza; Alonso de la Rivera; Natalie Espinoza; Natalia Armijo; Luis E Castañeda; Mauricio J Farfán; Carolina Salas
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

9.  The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center.

Authors:  Emaad Abdel-Kahaar; Stefan Winter; Roman Tremmel; Elke Schaeffeler; Christoph J Olbricht; Eberhard Wieland; Matthias Schwab; Maria Shipkova; Simon U Jaeger
Journal:  Front Genet       Date:  2019-09-26       Impact factor: 4.599

10.  Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Authors:  Jing Zhu; Tejendra Patel; Jordan A Miller; Chad D Torrice; Mehak Aggarwal; Margaret R Sketch; Maurice D Alexander; Paul M Armistead; James M Coghill; Tatjana Grgic; Katarzyna J Jamieson; Jonathan R Ptachcinski; Marcie L Riches; Jonathan S Serody; John L Schmitz; J Ryan Shaw; Thomas C Shea; Oscar Suzuki; Benjamin G Vincent; William A Wood; Kamakshi V Rao; Tim Wiltshire; Eric T Weimer; Daniel J Crona
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.